Stock 7447 NAGAILEBEN CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nagaileben Co., Ltd.

Equities

7447

JP3647000003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2,351 JPY +0.86% Intraday chart for Nagaileben Co., Ltd. +3.30% -1.30%
Apr. 02 Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.57% for ¥1,000 million. CI
Apr. 02 Nagaileben Co., Ltd. authorizes a Buyback Plan. CI

Valuation

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 69,266 89,509 83,939 58,151 71,047 74,814 - -
Enterprise Value (EV) 1 44,109 63,863 56,060 29,591 43,888 74,814 74,814 74,814
P/E ratio 20.1 x 25.8 x 23 x 16.9 x 22.1 x 24.1 x 23.4 x 22.7 x
Yield 2.88% 2.2% 2.35% 3.07% 2.72% 2.55% 2.55% 2.55%
Capitalization / Revenue 4.13 x 5.24 x 4.78 x 3.28 x 4.14 x 4.35 x 4.2 x 4.07 x
EV / Revenue 4.13 x 5.24 x 4.78 x 3.28 x 4.14 x 4.35 x 4.2 x 4.07 x
EV / EBITDA 13.2 x 17 x 15.2 x 10.9 x - 16 x 15.4 x 14.8 x
EV / FCF 21,591,536 x 25,937,046 x - - 44,238,678 x - - -
FCF Yield 0% 0% - - 0% - - -
Price to Book 1.74 x 2.23 x 2 x 1.49 x 1.64 x 1.71 x 1.66 x 1.61 x
Nbr of stocks (in thousands) 33,253 32,859 32,866 29,760 32,177 31,822 - -
Reference price 2 2,083 2,724 2,554 1,954 2,208 2,351 2,351 2,351
Announcement Date 10/3/19 10/1/20 10/4/21 10/3/22 10/2/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 16,785 17,066 17,563 17,745 17,181 17,200 17,800 18,400
EBITDA 1 5,255 5,271 5,528 5,315 - 4,670 4,870 5,070
EBIT 1 4,918 4,937 5,212 5,031 4,604 4,400 4,600 4,800
Operating Margin 29.3% 28.93% 29.68% 28.35% 26.8% 25.58% 25.84% 26.09%
Earnings before Tax (EBT) 1 4,988 5,030 5,288 5,468 4,671 4,500 4,700 4,900
Net income 1 3,445 3,474 3,647 3,778 3,226 3,100 3,200 3,300
Net margin 20.52% 20.36% 20.77% 21.29% 18.78% 18.02% 17.98% 17.93%
EPS 2 103.6 105.5 111.0 115.8 100.0 97.40 100.6 103.7
Free Cash Flow 3,208 3,451 - - 1,606 - - -
FCF margin 19.11% 20.22% - - 9.35% - - -
FCF Conversion (EBITDA) 61.05% 65.47% - - - - - -
FCF Conversion (Net income) 93.12% 99.34% - - 49.78% - - -
Dividend per Share 2 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00
Announcement Date 10/3/19 10/1/20 10/4/21 10/3/22 10/2/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: August 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3 2024 Q4 2024 S2
Net sales 1 7,051 10,015 8,069 9,494 3,378 4,439 7,817 5,800 4,128 9,928 2,954 4,977 7,931 5,256 3,048 7,392 5,591 4,220 9,811
EBITDA - - - - - - - - - - - - - - - - - - -
EBIT 1 1,739 3,198 2,275 2,937 915 1,120 2,035 1,905 1,091 2,996 631 1,228 1,859 1,681 657 1,608 1,733 1,060 2,793
Operating Margin 24.66% 31.93% 28.19% 30.94% 27.09% 25.23% 26.03% 32.84% 26.43% 30.18% 21.36% 24.67% 23.44% 31.98% 21.56% 21.75% 31% 25.12% 28.47%
Earnings before Tax (EBT) 1 1,793 3,237 2,313 2,975 940 1,137 2,077 2,268 - - 648 - 1,889 1,708 676 1,639 1,753 1,108 2,861
Net income 1 1,236 2,238 1,595 2,052 648 785 1,433 1,569 776 2,345 445 850 1,295 1,185 464 1,129 1,160 811 1,971
Net margin 17.53% 22.35% 19.77% 21.61% 19.18% 17.68% 18.33% 27.05% 18.8% 23.62% 15.06% 17.08% 16.33% 22.55% 15.22% 15.27% 20.75% 19.22% 20.09%
EPS 37.45 - 48.57 - 19.74 - 43.63 48.02 - - 13.82 - 40.16 36.73 14.53 35.39 - - -
Dividend per Share - - - - - - - - - - - - - - - - - - -
Announcement Date 4/2/20 10/1/20 4/5/21 10/4/21 12/27/21 4/4/22 4/4/22 6/29/22 10/3/22 10/3/22 12/27/22 4/4/23 4/4/23 6/29/23 12/27/23 4/2/24 - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 25,157 25,646 27,879 28,560 27,159 - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 3,208 3,451 - - 1,606 - - -
ROE (net income / shareholders' equity) 8.8% 8.7% 8.9% 9% 7.5% 7.1% 7.2% 7.2%
ROA (Net income/ Total Assets) 11.5% 11.3% 11.6% 11% 9.87% 9.2% 9.3% 9.5%
Assets 1 30,005 30,801 31,397 34,470 32,696 33,696 34,409 34,737
Book Value Per Share 2 1,195 1,221 1,279 1,310 1,346 1,377 1,418 1,461
Cash Flow per Share 114.0 116.0 121.0 124.0 108.0 - - -
Capex 1 225 146 239 94.2 206 200 250 250
Capex / Sales 1.34% 0.85% 1.36% 0.53% 1.2% 1.16% 1.4% 1.36%
Announcement Date 10/3/19 10/1/20 10/4/21 10/3/22 10/2/23 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Nagaileben Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
2,351 JPY
Average target price
2,000 JPY
Spread / Average Target
-14.93%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
NAGAILEBEN CO., LTD. Stock Nagaileben Co., Ltd.
-1.30% 475M
COLOPLAST A/S Stock Coloplast A/S
+11.84% 27.79B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-32.98% 2.98B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-15.97% 2.52B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+11.90% 2.34B
HARTALEGA HOLDINGS Stock Hartalega Holdings
-1.11% 1.91B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
-7.78% 1.39B
NAKANISHI INC. Stock Nakanishi Inc.
-0.38% 1.27B
KANGJI MEDICAL HOLDINGS LIMITED Stock Kangji Medical Holdings Limited
+4.01% 1.13B
KOSSAN RUBBER INDUSTRIES Stock Kossan Rubber Industries
+13.51% 1.12B
Medical Supplies
  1. Stock Market
  2. Equities
  3. 7447 Stock
  4. Financials Nagaileben Co., Ltd.